We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Agfa Healthcare

Provides integrated IT solutions, state-of-the-art diagnostic imaging and contrast media solutions for hospitals and ... read more Featured Products: More products

Download Mobile App




Enterprise Imaging Viewer Receives Clearance for Additional Apps

By HospiMedica International staff writers
Posted on 15 Aug 2017
A major medical hardware and software provider has received US FDA 510(k) clearance for additional functionalities on its enterprise imaging zero-footprint viewer.

The viewer merges patient images and data from different departments and various sources in a hospital. More...
Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.

The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.

The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.

The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.

President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Medical Examination & Procedure Light
Vega 80
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.